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Summary: The Maltese population has been shown to have a high incidence of endometrial 
adenocarcinoma when compared to other European countries. This high incidence has been cor-
related to the high prevalence of abnormal glucose metabolism and rather high dietary fat intake 
in the Maltese population. Hypertension and low parity were also found to be more frequent in 
the carcinoma group. 
INTRODUCTION 
The endometrium is the fourth most 
common site of invasive carcinoma in wo-
men and the most common gynaecological 
malignancy. Endometrial adenocarcinoma 
constitutes over 90% of the neoplasms in-
volving the uterine corpus. For many 
years there had been a relative lack of 
interest in endometrial cancer by onco-
logists because of its low virluence and 
correspondingly low mortality rate rela-
tive to other cancers. The realization that 
this cancer was probably a hormone de-
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pendant malignancy revived interest in 
the epidemiology of the disease. It has 
now been associated with women who 
were the subjects of constant oestrogen 
stimulation without progestational modifi-
cation. This study attempts to review 
some epidemiological features of endome-
trial carcinoma in the Maltese popula-
tion. This population in 1981 comprised 
a relatively closed community of 319936 
individuals, with a female-male ratio of 
1.3, about 23.7% of the female population 
were aged 50 years or more e). The Mal-
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Rates per 100000 female population. 
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Fig. 1. - Incidence and mortality rates European Region. 
incidence of a malignancy commoner in 
tese population has been found to have 
a high prevalence of Type II diabetes mel-
litus and impaired glucose tolerance (16), 
conditions which have been associated 
with an increased risk of endometrial 
cancer. 
MATERIAL AND METHODS 
The records of all the patients with endo-
metrial adenocarcinoma diagnosed by hystopatho-
logy at St. Luke's Hospital, Malta during the 
1979-1983 period were reviewed. St. Luke's 
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Hospital is the main hospital in the Maltese Ar-
chipelago accounting for a very large percentage 
of major operations performed on the Islands. 
Patients with endometrial adenocarcinoma are 
very likely to be referred to this hospital. Thus 
statistic from the hospital may be considered to 
be representative for the whole Maltese popu-
lation. 
During the period 1979-1983, there were a 
total of 121 new cases of endometrial adenocar-
cinoma diagnosed by his to-pathology, giving an 
overall national incidence of 14.6 per 100,000 
female population. Of these cases, 17 were ex-
cluded from the epidemiological study because 
the case records could not be traced, though 
data regarding the patient's age and locality was 
available. The National statistics were obtained 
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Fig. 2. - Trends in incidence and mortality rates of uterine corpus malignancy in Malta. 
from published sources (3, 4) and from the Can· 
cer Notification records of the Department of 
Health in Malta. 
INCIDENCE PATTERNS 
The vital statistics of this type of can-
cer, in terms of international comparisons, 
are difficult to evaluate since endometrial 
adenocarcinoma is often recorded together 
with other malignancies of the corpus ute-
ri. The latter group comprising sarcomas 
and mesodermal tumours account for only 
a small proportion of cases. During the 
period 1979-1983, these tumours accoun-
ted for 12.9% of all corpus uteri malig-
nancies diagnosed at St. Luke's Hospital. 
There is little reliable comparable infor-
mation available on endometrial cancer in 
different regions of the world. Informa-
tion based on the International Classifi-
cation of Disease eZ) presented in figure 1 
shows the Maltese population to have a 
high incidence of corpus uteri malignan-
cies as compared to other European coun-
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tries. There is however a wide incidence 
range between different populations, so 
that a very high (38.5) and a very low 
(1.7) incidence has been reported from 
D.S.A. (Albanea, white) and Japan respec-
tively. The mortality rate from uterine 
malignancy in the Maltese Islands appears 
to be lower than in most other coun-
tries (23,24). There appears to be a slight 
difference in the incidence of endometrial 
carcinoma in the populations of the two 
main islands of the Maltese Archipelago. 
Thus during the period 1979-1983, there 
were 10 cases of adenocarcinoma from 
Gozo and 111 cases from Malta, giving 
an annual incidence of 16.1 and 14.9 per 
100,000 female population respectively. 
The increased incidence for Gozo may be 
a result of a more elderly population on 
the island. 
The incidence of uterine malignancy in 
the Maltese population has varied consi-
derably in the last 20 years. Figure 2 
shows a rise after 1965 followed by a 
gradual dowunard trend reaching an inci-
dence of 5.0 per 100,000 female popula-
tion. After 1977, there was again a sharp 
rise to levels of 19.2 per 100,000 females. 
The incidence has since persisted at 
around this level. A similar rise in in-
cidence rates of endometrial carcinoma 
has been noted for other countries e4). It 
is difficult to explain the rise in the in-
cidence after 1977, especially when com-
pared to the mortality rates from uterine 
malignancies which appear to follow a 
gradual downward trend (figure 2). Misin-
terpretation of some complex hyperplasias 
and metaplasias as carcinoma may partly 
account for the rise. The increased inci-
dence may also be result of variations in 
the reporting of cases in different years. 
This may be partly confirmed by the si-
milar patterns which may be noted in the 
incidence of cervical and breast malignan-
cies. 
The increase in the life expectancy of 
a population could possibly influence the 
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the elderly. While life exectancy has 
improved in the Maltese population, the 
differences are too small to account for 
the different incidence rates. Thus in 
1961, 20.3% of women were over 50 
years of age, while in 1981 this age group 
included 23.7 % of the female popula-
tion n. The age group distribution of 
the cases with endometrial adenocarcino-
ma during the period 1979-1983 confirms 
that the patients most at risk are aged 
over 60 years (table 1). 
Table 1. - Age distribution of endometrial 
adenocarcinoma Maltese Islands 1979-1983. 
Number of Maltese Incidence Age 
carcinoma % distribution per 100,000 (years) 
cases by age female 1979-1983 population 
under 20 nil 30.14 nil 
50 -59 25 10.38 29.1 
20- 39 7 34.32 2.5 
40-49 14 11.51 14.7 
50-59 25 10.38 29.1 
60- 69 38 7.19 63.9 
70-79 30 4.97 73.0 
over 80 7 1.49 57.0 
Total 121 100.0 14.6 
CLINICAL ASSOCIATION 
Discussions concerning the aetiology of 
endometrial adenocarcinoma have centered 
largely around the possible role of oestro-
gen in producing this malignancy. Such 
attention was inevitable given the known 
proliferative effect oestrogen has on the 
endometrium, and the association of en-
dometrial hyperplasia with prolonged un-
opposed oestrogen stimulation. There is 
a considerable body of circumstantial evi-
dence to implicate both endogenous and 
exogenous oestrogens in the evolution of 
endometrial carcinoma (8). Much of this 
evidence is related indirectly to a number 
of clinical features which have been sta-
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tistically correlated to be associated with 
endometrial adenocarcinoma. 
Obesity 
The most common clinical correlate of 
endometrial carcinoma is obesity with a 
reported incidence of 21 to over 80% (la). 
In the study population, 50% of the pa-
tients were identified by the clinicians 
attending the cases as being obese. How-
I 
metrial cancer (25). Armstrong and Doll (I) 
related the incidence of endometrial can-
cer to national levels of dietary fat con-
sumption and concluded that dietary fat 
or calorie level is a significant factor in 
determining the individual's risk of deve-
loping endometrial adenocarcinoma. The 
Maltese consume large amounts of food 
with an average energy intake in females 
of about 6.5 MJ. Total fat account for 
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Fig. 3. - Correlation between incidence of cancer corpus uteri and total consumption. (After: 
Armstrong and Doll, 1975 and data from Malta after Vuksan, 1984 and present series). 
ever obesity is one of the most important 
socio-medical problems effecting the Mal-
tese population. More than 60% of the 
male population, and an even higher per-
centage of females suffer from excessive 
body weight e1). Life style and nutritio-
nal factors in the induction of cancer have 
been the subject of many investiga-
tions eO). Body weight at the time of the 
menopause is correlated with postmeno-
pausal endometrial adenocarcinoma, and 
obesity has been suggested to be the most 
important factor in the induction of endo-
approximately 45.6% of this intake e1). 
The incidence of endometrial carcinoma 
correlated to the total fat consumption of 
the population (figure 3) compares favou-
rably with the correlation identified by 
Armstrong and Doll (I). The biochemical 
role of obesity in the aetiology of endo-
metrial carcinoma has been attributed to 
aromatization of circulating androstenedio-
ne in adipose tissue (11) accounting for the 
elevated oestrogen excretion in the obese 
woman (IS). Similarly elevated peripheral 
blood levels of oestrone have been re-
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ported in women with overt diabetes mel-
litus (5). 
Diabetes meWtus 
It has frequently been suggested that 
diabetes mellitus may be associated with 
an increased endometrial cancer risk, 
though the reports are conflicting. Mac 
Mahon (13) reported a relative risk of 2.8 
associated with a history of diabetes even 
after controlling for age, body weight and 
socio-economic status. The Maltese Is-
lands have been shown to have a high 
prevalence of diabetes mellitus and im-
paired glucose tolerance as compared to 
other countries. The prevalence of dia-
betes mellitus in women aged 45 years 
or more ranges between 14-29% depen-
ding on the age group e6). This high pre-
valence may in part account for the hi-
gher incidence of endometrial carcinoma 
reported for the Islands. In the study 
population, 35.6% of the patients had a 
fasting blood glucose greater or equal to 
7.0 mmoljl. 
Hypertension 
Another nutritionally related disease is 
hypertension, which has been correlated 
to high animal fat diets. Some studies 
have shown a positive association between 
endom.etrial cancer and hypertension, but 
the eVldence is again conflicting (13, 25). In 
the study population 71.2% of the cases 
were found to be hypertensive when first 
seen. In a random sample of 150 females 
aged more than 50 years attending the 
gynaecology clinic for conditions other 
than endometrial carcinoma, 61.3% were 
found to be hypertensive. 
Other associated conditions 
Other conditions may be responsable 
for the increased peripheral oestrone for-
mation from precursors, the process being 
more efficient again in women. Thus wo-
men with polycystic: ovarian disease pro-
duce three to four times more androste-
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nedione than normal women, and also 
greater peripheral quantities of oestro-
ne (17). Tumours and hyperplasia of the 
ovarian stroma are also associaed with in-
creased androstenedione production e2). 
Patients with these conditions have been 
reported to have an increased risk of en-
dometrial hyperplasia and adenocarcino-
ma C), though the incidence of these di-
sorders with endometrial adenocarcinoma 
in the study population appears to be low 
(table 2). An association with uterine 
leiomyomas has also been described and 
related to the suggestion that oestrogens 
may be important in the development and 
maintainance of leiomyomas. Oestradiol 
levels are sometimes increased in women 
with leiomyomas, and one study (6) has 
shown that the smooth muscle cells in 
leiomyomas will bind oestradiol. 
Uterine smooth muscle tumours were 
present in 11.5 % of cases in the study 
population (table 2). The annual inciden-
ce of histologically proved uterine smooth 
muscle tumours in the Maltese population 
aged over 20 years is about 104 per 
100,000, the majority being in the 40-49 
years age group. The annual incidence of 
malignant uterine smooth muscle tumours 
i~ about 2.5 per 100,000 female popula-
tlOn aged over 20 years. Maltese fema-
les with histologically diagnosed uterine 
Table 2. - Associated conditions with endo-
metrial carcinoma Maltese Islands 1979-1983. 
Associated conditions No. % 
Uterine smooth muscle tumors (1) 12 11.5 
Ovarian cysts/tumours (2) 10 9.6 
Breast carcinoma 2 1.9 
Thyroid disease 2 1.9 
Other disorders (3) 5 4.0 
(1) one case of leiomyosarcoma 
(2) one case of oestrogen secreting granulosa cell 
tumour, and one case of adenocarcinoma 
(3) single cases o~ stomach leiomyoma, forehead 
basal cell carCInoma, and endometriosis. Two 
cases of adenomyosis. 
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Table 3. - Parity distribution of endometrial 
adenocarcinoma Maltese Islands 1979-1983. 
Parity No. % 
PO 48 46.2 
PI 4 3.9 
P2 7 6.7 
P3 9 8.7 
P4 7 6.7 
P5 29 27.8 
Total 104 100.0 
smooth muscle tumours had a 1.4 % 
chance having an associated endometrial 
carcinoma (18). A correlation to endome-
trial adenocarcinoma has been described 
for long-term oestrogen therapy eO), 
though there is no evidence that combined 
oral contraceptives are associated with an 
altered incidence of endometrial neoplasia. 
Progestogens have been shown to re-
verse both spontaneously arising and oes-
trogen induced endometrial hyperplasia, 
and to have a protective effect against the 
development of adenocarcinoma. This ac-
tion is probably a result of an antioestro-
gen effect on uterine epithelial cells (8). 
Patients with endometrial carcinoma 
have also been reported as having a history 
of dysfunctional uterine bleeding or se-
condary amenorrhoea, often reported to 
be the result of anovulation. Additionally, 
these patients are relatively infertile and 
of low parity. While a previous history 
of dysfunctional uterine bleeding was dif-
ficult to establish in the study population, 
46.2% were found to be nulliparous con-
firming previous findings. High fertility 
however is not completely exclusive of 
endometrial carcinoma, so that 27 .8% of 
the cases had five or more children (table 
3). The correlation between nulliparity 
and endometrial adenocarcinoma does not 
appear to be related to anovulation alone, 
since of the 48 patients who were nulli-
parous 56.3% were unmarried and had 
never attempted to get pregnant. There 
have been some suggestions that different 
forms of oestrogens may have carcino-
genic or protective effects. One theory 
proposes that oestriol may protect against 
breast and endometrial cancer e). This 
theory was based on the observation that 
breast cancer and endometrial cancer pa-
tients have lower oestriol: oestrone and 
oestradiol ratios than normal postmeno-
pausal women. Since oestriol levels are 
known to increase during pregnancy, mul-
tiparous women may have a lower risk 
of developing breast or endometrial cancer. 
Breast cancer has been related to uterine 
adenocarcinoma e) and shown to have 
similar risk factors. This relationship may 
however be fortuitous since both condi-
tions are common in the female popu-
lation. The study population revealed two 
cases (1.9%) of uterine adenocarcinoma 
who had breast malignancy confirmed 
previously. The incidence of breast carci-
noma in the Maltese female population is 
about 0.05%. Thyroid dysfunction has 
also been correlated with endometrial 
carcinoma, possibly by interfering with the 
cholesterol mechanism (19). Only two 
cases of the study population had a pre-
vious history of thyroid disease, both 
patients were euthyroid. 
CONCLUSION 
The fundamental purpose of epidemio-
logy is not only to uncover new infor-
mation about aetiologies, but to determine 
measures which may contribute to the 
decline in the incidence of the disease. It 
would appear that a number of risk fac-
tors may be associated with the aetiology 
of endometrial carcinoma. Rarely does one 
encounter a patient with endometrial car-
cinoma who does not present at least one 
of the disorders that constitute the "cancer 
traid", i.e. obesity, diabetes mellitus and 
hypertension. 
Preventive action can be considered for 
patients at risk, thus helping decrease the 
incidence of endometrial carcinoma, parti-
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cularly if related to a high animal fat 
diet. It therefore becomes desirable to 
avoid or reduce obesity to decrease the 
risk of endometrial adenocarcinoma. Pre-
sumably the earlier the weight reduction, 
the better the prognosis. 
Oestrogen replacement therapy offers 
risks and benefits. The benefits appear 
to be in the relief of specific symptoms 
of hypoestrogenism. These include vaso-
motor hot flushes and atrophic vaginitis. 
There is also evidence that oestrogens re-
duce the incidence of certain metabolic 
disorders, such as cardiovascular disease 
and osteoporosis. The increased risk of 
endometrial cancer is at present the most 
important known drawback to the use of 
non-contraceptive oestrogen preparations. 
Available data suggest that this risk can 
be lessened by the use of a progestogen 
in oestrogen-treated postmenopausal wo-
men, as well as those at high risk for 
developing endometrial adenocarcinoma. 
The identification of high risk groups 
facilitates screening efforts directed at the 
population at risk. A variety of instru-
ments for endometrial sampling on an 
outpatient basis have been described. The 
approaches to endometrial diagnostic 
sampling can be classified into two groups: 
examination of tissue samples and cyto-
logic procedures. The diagnostic efficacy 
of the endometrial biopsy instruments is 
adequate, but difficult to use for screen-
ing purposes. Although cytologic samples 
obtained by various methods are helpful 
in screening a large number of patients, 
a high false-negative rate limits the use-
fulness of cytology in diagnosing endo-
metrial carcinoma and pre-cancerous 
lesions. 
The immediate investigation of women 
with abnormal vaginal bleeding would 
seem to be the most practical means of 
improving the end results in this disease 
at the present time. Complete evaluation 
of a case with abnormal uterine bleeding 
in the perimenopausal and postmenopausal 
age groups should include dilatation and 
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fractional curettage to establish the diag-
nosis. 
The majority of cases of endometrial 
adenocarcinoma generally present early in 
the course of the disease. However al-
though unproved, it appears likely, that 
at least some patients who are first seen 
with a prognostically unfavourable ad-
vanced stage of the disease had an asymp-
tomatic stage of tumour development. 
Therefore, the question of feasibility of 
screening for endometrial cancer in suitab-
ly identified target populations must be 
raised and needs to be investigated further. 
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